Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
COVID-19
Renin-angiotensin-aldosterone system
Journal
Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
15
06
2020
revised:
15
06
2020
accepted:
15
06
2020
pubmed:
23
6
2020
medline:
4
9
2020
entrez:
23
6
2020
Statut:
ppublish
Résumé
The pathophysiology of acute kidney injury (AKI) in COVID-19 patients is still poorly understood. SARS-CoV-2 has been suggested to modulate the renin-angiotensin-aldosterone system (RAAS). In this series of COVID-19 critically ill patients, we report evidence of activation of the RAAS in COVID-19 patients with AKI.
Identifiants
pubmed: 32565254
pii: S2352-5568(20)30107-7
doi: 10.1016/j.accpm.2020.06.006
pmc: PMC7301818
pii:
doi:
Substances chimiques
Aldosterone
4964P6T9RB
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
453-455Informations de copyright
Copyright © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.
Références
N Engl J Med. 2020 Jun 4;382(23):2238-2247
pubmed: 32492305
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nephron. 2019;143(3):179-183
pubmed: 30999307
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
Intensive Care Med. 2018 May;44(5):598-605
pubmed: 29766216
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632